AMSA Pharm-free Scorecard 2010
A Emory University School of Medicine
City: Atlanta State: GA

Summary: Emory University School of Medicine has a model policy regarding consulting, speaking, purchasing/formularies, off-site education and scholarships/trainee funds.  The gifts policy is strong and even though it scores as an "ideal policy", it would benefit from a stronger and clearer ban on unsolicited food or gift baskets. Requiring public disclosure of personnel financial conflicts of interest could increase the institution's disclosure domain score. Oversight and sanctions are clearly referenced. An additional area of improvement would be the curriculum, which is limited, from what we saw, and fails to promote a full understanding of pharmaceutical marketing and conflicts of interest. The samples policy decreased in grade this year due to the statement in the newly submitted policy reserving samples for the use in "needy" populations. This may be appropriate, and maybe manifested as an ideal policy, but should be clarified further.

Demographics:  On average students spend 40% of their training at Grady Hospital, 20% at Emory Hospitals and 15% at Children's Healthcare of Atlanta. Policies apply to students at all sites; however it is unclear how the policies apply to faculty and clinical educators at various sites.

UpdatesThis institution did not submit any new or additional policies for the 2012-13 AMSA PharmFree Scorecard.This institution's evaluation was last updated: 1/18/2012

Gifts & Meals 3 Regardless of nature, gifts are prohibited on and off campus.  The solicitation and acceptance of food or the like is prohibited.
Consulting relationships 3 Although no formal contract is required, there is a requirement for institutional review, via Department Chair or Dean's Office.  In addition, the institutional review is the provision to ensure that payment is appropriate to the task.
Industry-funded speaking relationships 3 The policy explicitly prohibits the participation in "speaker's bureaus" and the policy prevents industry from controlling the content of the speaker or trainer's presentation.
Disclosure 2 The policy requires disclosure of financial ties throughout the year and annually, via an on-line reporting system.
Pharmaceutical samples 2 Samples are not completely prohibited from the institution, yet the policy explicitly prohibits the acceptance of samples by a physician, from a pharmaceutical sales representative.  New policy states samples can be given in "needy" instances.
Purchasing & Formularies 3 Committee members with financial conflicts of interest are required to recuse themselves from making or participating in a decision involving the conflict of interest organization.
Industry Sales Representatives 2 Industry sales representatives are allowed to meet with faculty, but only by appointment and post registration and vendor approval process, through an online system.
On-campus Education 3 Funds from industry to support education and other professional activities must be made to the Development Office and can only be disgnated to very broad educational categories such as "internal medicine".  Industry can have no influence over content nor can any quid pro quo exist.
Attendance at Industry-Sponsored Lectures & Meetings Off-Campus 3 The policy prohibits the receipt of payment for attendance at off-site events.  Financial support by industry for faculty travel to off-site events for the provision of education and training activities are subject to advanced review and approval from the Department Chair and Dean's Office.
Industry Support for Scholarships & Funds for Trainees 3 The policy allows industry to "earmark broad areas of interest," but prevents industry from selecting the individual recipient of the funds.
Medical school curriculum 2 The supplied curriculum covered the school's policies adequately, but failed to discuss how industry marketing and relationships can effect healthcare practice.
Do the policies specify an oversight mechanism? Yes The policy highlights various departments, depending on the nature of the violation, as responsible for general oversight to ensure compliance.  The parties include the following: Healthcare Compliance Office, Human Resources, Conflict of Interest in Research Office, etc.
Are there explicit sanctions for noncompliance? Yes Each case of noncompliance is addressed by the Dean's Office which may apply various degrees of disciplinary action.
What the results mean...
3Model policy
2Good progress toward model policy
1No policy, or policy unlikely to have a substantial effect on behavior
0Did not report
N/APolicy not relevant to this institution (e.g., does not make purchasing decisions)